These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35201275)

  • 1. Association Between the BNT162b2 Messenger RNA COVID-19 Vaccine and the Risk of Sudden Sensorineural Hearing Loss.
    Yanir Y; Doweck I; Shibli R; Najjar-Debbiny R; Saliba W
    JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):299-306. PubMed ID: 35201275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden Hearing Loss Following Vaccination Against COVID-19.
    Nieminen TA; Kivekäs I; Artama M; Nohynek H; Kujansivu J; Hovi P
    JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):133-140. PubMed ID: 36520464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Audiometry-Confirmed Sudden Sensorineural Hearing Loss Incidence among COVID-19 Patients and BNT162b2 Vaccine Recipients.
    Cohen Michael O; Tamir SO; O'Rourke N; Marom T
    Otol Neurotol; 2023 Feb; 44(2):e68-e72. PubMed ID: 36624589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.
    Formeister EJ; Wu MJ; Chari DA; Meek R; Rauch SD; Remenschneider AK; Quesnel AM; de Venecia R; Lee DJ; Chien W; Stewart CM; Galaiya D; Kozin ED; Sun DQ
    JAMA Otolaryngol Head Neck Surg; 2022 Apr; 148(4):307-315. PubMed ID: 35201274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database.
    Thai-Van H; Valnet-Rabier MB; Anciaux M; Lambert A; Maurier A; Cottin J; Pietri T; Destère A; Damin-Pernik M; Perrouin F; Bagheri H
    JMIR Public Health Surveill; 2023 Jul; 9():e45263. PubMed ID: 37071555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden Sensorineural Hearing Loss Following Immunization With BNT162b2 or mRNA-1273: A Danish Population-Based Cohort Study.
    Damkier P; Cleary B; Hallas J; Schmidt JH; Ladebo L; Jensen PB; Lund LC
    Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1472-1480. PubMed ID: 37288514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
    Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
    JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis: A Population-Based Study.
    Tomkins-Netzer O; Sar S; Barnett-Griness O; Friedman B; Shyriaieva H; Saliba W
    Ophthalmology; 2022 Oct; 129(10):1087-1095. PubMed ID: 35643168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand.
    Walton M; Pletzer V; Teunissen T; Lumley T; Hanlon T
    Drug Saf; 2023 Sep; 46(9):867-879. PubMed ID: 37556109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.
    Buchan SA; Alley S; Seo CY; Johnson C; Kwong JC; Nasreen S; Thampi N; Lu D; Harris TM; Calzavara A; Wilson SE
    JAMA Pediatr; 2023 Apr; 177(4):410-418. PubMed ID: 36848096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Report of Sudden Sensorineural Hearing Loss (SSNHL) After Administration of the COVID-19 Vaccine.
    Andrade J; Sessa L; Ephrat M; Truong J; DiGregorio R
    J Pharm Pract; 2024 Jun; 37(3):753-757. PubMed ID: 36537083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults.
    Harris DA; Hayes KN; Zullo AR; Mor V; Chachlani P; Deng Y; McCarthy EP; Djibo DA; McMahill-Walraven CN; Gravenstein S
    JAMA Netw Open; 2023 Aug; 6(8):e2326852. PubMed ID: 37531110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    Goldshtein I; Nevo D; Steinberg DM; Rotem RS; Gorfine M; Chodick G; Segal Y
    JAMA; 2021 Aug; 326(8):728-735. PubMed ID: 34251417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine.
    Akpandak I; Miller DC; Sun Y; Arnold BF; Kelly JD; Acharya NR
    JAMA Netw Open; 2022 Nov; 5(11):e2242240. PubMed ID: 36383382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine.
    McGrath LJ; Malhotra D; Miles AC; Welch VL; Di Fusco M; Surinach A; Barthel A; Alfred T; Jodar L; McLaughlin JM
    JAMA Netw Open; 2023 Nov; 6(11):e2342151. PubMed ID: 37938846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
    Mevorach D; Anis E; Cedar N; Bromberg M; Haas EJ; Nadir E; Olsha-Castell S; Arad D; Hasin T; Levi N; Asleh R; Amir O; Meir K; Cohen D; Dichtiar R; Novick D; Hershkovitz Y; Dagan R; Leitersdorf I; Ben-Ami R; Miskin I; Saliba W; Muhsen K; Levi Y; Green MS; Keinan-Boker L; Alroy-Preis S
    N Engl J Med; 2021 Dec; 385(23):2140-2149. PubMed ID: 34614328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study.
    Shibli R; Barnett O; Abu-Full Z; Gronich N; Najjar-Debbiny R; Doweck I; Rennert G; Saliba W
    Lancet Reg Health Eur; 2021 Dec; 11():100236. PubMed ID: 34751262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis.
    John BV; Deng Y; Scheinberg A; Mahmud N; Taddei TH; Kaplan D; Labrada M; Baracco G; Dahman B
    JAMA Intern Med; 2021 Oct; 181(10):1306-1314. PubMed ID: 34254978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.